Biotech News & Trading Forum: Community User: Weedmaster

NEW YORK, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that the European Patent Office ("EPO") issued European Patent No. 2968992 to the Company on December 11, 2019. This patent, “Eutectic Formulations of Cyclobenzaprine Hydrochloride and Mannitol,” includes 14 claims directed to compositions comprising eutectics of cyclobenzaprine hydrochloride and mannitol and methods of making those compositions. This patent is expected to provide Tonix with market exclusivity until 2034. Seth Lederman, M.D., President and Chief Executive Officer of Tonix commented, “The issuance of this European patent is an important step forward in our efforts to broaden our intellectual property estate on a global basis for TNX-102 SL*.” Tonix’s proprietary eutectic formulation of cyclobenzaprine, or TNX-102 SL, is designed for chronic sublingual (under-the-tongue) administration daily at bedtime, which the Company believes facilitates transmucosal absorption of cyclobenzaprine and bypasses first pass liver metabolism. Marketed cyclobenzaprine drug products are limited to short-term use (two to three weeks) and formulated for oral ingestion, which results in significant liver metabolism. Sublingual TNX-102 SL has a different pharmacokinetic profile than marketed oral cyclobenzaprine drug products. TNX-102 SL is being developed as a treatment for four indications: posttraumatic stress disorder (PTSD), fibromyalgia, agitation in Alzheimer’s disease and alcohol use disorder. Marketed oral cyclobenzaprine products are indicated for the relief of muscle spasm.

$TNXP closed strong in after-hours +25% trading nearly the entire float. After CEI, i think the money will flow into this name. Squeeze over 1.30 targeting the 2.25 zone. Plus, there is a gap to fill over 1.87. As i said on $CEI when it comes to low float names, everything is possible, they can double or triple in a single day and volume precedes price. Usually, before a stock price moves, the volume comes into play. The after-hours trading, was the signal.

Tonix💪

Tocagen Gap Close? 🤔 Will nicht so beschieden sein 4,40$ 😅

Gailooooooooooooooooo!! 😀✌️👊

Gedankenleser? 🤔 😂

Ohne h natürlich 😅

Tocagehn startet 🙈

bluebird bio (BLUE) Presents At 2019 ASH Annual Meeting - Slideshow https://seekingalpha.com/article/4311921?source=ansh $BLUE

38 US Cent 😅

Hat jemand News wegen Intellipharmaceutics? 🤔 Depressionsmedikament?

Tatsächlich Schorsch. 😅 Hab gerade nur Augen für Proteostasis 😂

Das Volumen ist ja süß

Ich wollte es grad schreiben ...Crazy Going! Ich gratuliere und warte auf einen Rücksetzer 😅

Moma unsere IPCI startet endlich 🥳🚀

Theranexus vor möglichen big breakout --ASK ist ziemlich dünn--https://uk.advfn.com/p.php?pid=staticchart&s=EU%5EALTHX&t=37&p=0&dm=0&vol=0&width=334&height=202&min_pre=0&min_after=0........... Theranexus --Kurs €2,50 --Marktkap €9 M --wird unter Cashbestand gehandelt -Aktienanzahl nur 3,6 Million ultra niedriger float -- Alzheimer Phase 1b Daten diesen monat -- Parkinson Phase 2b Daten nächstes Quartal = Potentieller 10 BAGGER und mehr drin bei guten resultaten .GL